Cellectis S.A.
ALCLS.PA · PAR
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | €151,107 | €129,980 | €151,657 |
| - Cash | €52,243 | €59,809 | €127,636 | €143,251 |
| + Debt | €29,252 | €94,773 | €91,768 | €91,461 |
| Enterprise Value | – | €186,071 | €94,112 | €99,867 |
| Revenue | €35,172 | €16,725 | €10,655 | €12,717 |
| % Growth | 110.3% | 57% | -16.2% | – |
| Gross Profit | €32,815 | €14,300 | €8,640 | €12,717 |
| % Margin | 93.3% | 85.5% | 81.1% | 100% |
| EBITDA | €7,707 | -€16,664 | -€11,285 | €14,174 |
| % Margin | 21.9% | -99.6% | -105.9% | 111.5% |
| Net Income | €589 | -€23,735 | -€18,128 | €5,922 |
| % Margin | 1.7% | -141.9% | -170.1% | 46.6% |
| EPS Diluted | 0.006 | -0.24 | -0.18 | 0.066 |
| % Growth | 102.5% | -33.3% | -373.1% | – |
| Operating Cash Flow | -€1,571 | -€10,310 | -€17,160 | -€47 |
| Capital Expenditures | -€1,181 | -€305 | -€395 | -€1,745 |
| Free Cash Flow | -€2,752 | -€10,615 | -€17,555 | -€1,792 |